Login / Signup

Calcineurin-AKAP interactions: therapeutic targeting of a pleiotropic enzyme with a little help from its friends.

Moriah GildartMichael S KapiloffKimberly L Dodge-Kafka
Published in: The Journal of physiology (2018)
The ubiquitous Ca2+ /calmodulin-dependent phosphatase calcineurin is a key regulator of pathological cardiac hypertrophy whose therapeutic targeting in heart disease has been elusive due to its role in other essential biological processes. Calcineurin is targeted to diverse intracellular compartments by association with scaffold proteins, including by multivalent A-kinase anchoring proteins (AKAPs) that bind protein kinase A and other important signalling enzymes determining cardiac myocyte function and phenotype. Calcineurin anchoring by AKAPs confers specificity to calcineurin function in the cardiac myocyte. Targeting of calcineurin 'signalosomes' may provide a rationale for inhibiting the phosphatase in disease.
Keyphrases
  • protein kinase
  • cancer therapy
  • left ventricular
  • clinical trial
  • drug delivery
  • signaling pathway
  • pulmonary hypertension
  • tyrosine kinase
  • structural basis